BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12001773)

  • 1. [Expression of p-glycoprotein in malignant solid human tumors].
    Grelewski PG; Bar JK
    Ginekol Pol; 2002 Feb; 73(2):133-41. PubMed ID: 12001773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversers of the multidrug resistance transporter P-glycoprotein.
    Stein WD
    Curr Opin Investig Drugs; 2002 May; 3(5):812-7. PubMed ID: 12090558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein in adult solid tumors. Expression and prognostic significance.
    Leighton JC; Goldstein LJ
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):251-73. PubMed ID: 7642464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug resistance in pediatric malignancies.
    Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein and membrane roles in multidrug resistance.
    Ferreira RJ; dos Santos DJ; Ferreira MJ
    Future Med Chem; 2015; 7(7):929-46. PubMed ID: 26061109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic significance of ectophosphatase inhibitors in reversal of multi-drug resistance.
    Kannan S
    Med Hypotheses; 2006; 66(5):1041-2. PubMed ID: 16446053
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in plant-based inhibitors of P-glycoprotein.
    Yu J; Zhou P; Asenso J; Yang XD; Wang C; Wei W
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):867-81. PubMed ID: 26932198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
    Fox E; Bates SE
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):447-59. PubMed ID: 17428165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of multidrug resistance in the therapy of malignant tumors].
    Pitlik E; Holló Z
    Orv Hetil; 1996 Dec; 137(50):2783-90. PubMed ID: 9679612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing multidrug resistance protein 1-mediated function in cancer cell multidrug resistance by scanning electrochemical microscopy and flow cytometry.
    Kuss S; Cornut R; Beaulieu I; Mezour MA; Annabi B; Mauzeroll J
    Bioelectrochemistry; 2011 Aug; 82(1):29-37. PubMed ID: 21620781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo monitoring of chemotherapy multidrug resistance (MDR)].
    Fraile M
    Rev Esp Med Nucl; 1999; 18(1):1-3. PubMed ID: 10383232
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multidrug or pleiotropic resistance].
    Arvelo F; Merentes E; Cotte C
    Acta Cient Venez; 2000; 51(1):45-52. PubMed ID: 10974707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
    Ballinger JR
    Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.
    Eid H; Bodrogi I; Csókay B; Oláh E; Bak M
    Anticancer Res; 1996; 16(6B):3447-52. PubMed ID: 9042205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu.
    Lwaleed BA; Cooper AJ
    Med Hypotheses; 2000 Dec; 55(6):470-3. PubMed ID: 11090292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms of multidrug resistance of tumor cells.
    Stavrovskaya AA
    Biochemistry (Mosc); 2000 Jan; 65(1):95-106. PubMed ID: 10702644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles.
    Cavaco MC; Pereira C; Kreutzer B; Gouveia LF; Silva-Lima B; Brito AM; Videira M
    Eur J Pharm Biopharm; 2017 Jan; 110():76-84. PubMed ID: 27810470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Overcoming of multidrug resistance and its clinical application].
    Tsuruo T
    Nihon Rinsho; 1997 May; 55(5):1111-5. PubMed ID: 9155161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.